Truist Financial Keeps Their Buy Rating on Sangamo Biosciences (SGMO)
Truist Financial analyst Nicole Germino maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of ...
Sangamo price target lowered to $5 from $7 at Truist
Truist analyst Nicole Germino lowered the firm’s price target on Sangamo (SGMO) to $5 from $7 and keeps a Buy rating on the shares. The firm ...
bovnews3d
Why Did Sangamo Therapeutics Inc (SGMO) Stock See 9.88% Surge in the Last 90 Days?
Sangamo Therapeutics Inc (SGMO) stock saw a decline, ending the day at $1.09 which represents a decrease of $-0.01 or -0.91% from the prior close of $1.1. The stock opened at $1.1 and touched a low of ...
Yahoo Finance6d
Sangamo Therapeutics, Inc. (SGMO)
RICHMOND, Calif., December 30, 2024--SANGAMO THERAPEUTICS TO REGAIN FULL RIGHTS TO HEMOPHILIA A GENE THERAPY PROGRAM FOLLOWING PFIZER’S DECISION TO CEASE DEVELOPMENT Astellas Pharma Inc. (TSE ...
Yahoo Finance3d
Sangamo Therapeutics, Inc. (SGMO)
After hours: January 21 at 6:57:18 p.m. EST ...
MarketWatch6d
Sangamo Therapeutics Inc.
Copyright © 2025 MarketWatch, Inc. All rights reserved.